EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,847,476 | +194.2% | 356,380 | +220.3% | 0.00% | – |
| Q2 2023 | $967,892 | +733.1% | 111,252 | +181.5% | 0.00% | – |
| Q1 2023 | $116,177 | -55.9% | 39,516 | -47.5% | 0.00% | – |
| Q4 2022 | $263,428 | -69.4% | 75,265 | -30.8% | 0.00% | – |
| Q3 2022 | $860,000 | -33.4% | 108,781 | -33.7% | 0.00% | – |
| Q2 2022 | $1,291,000 | -42.7% | 164,100 | -11.5% | 0.00% | – |
| Q1 2022 | $2,253,000 | -21.1% | 185,400 | -20.5% | 0.00% | – |
| Q4 2021 | $2,854,000 | +146.0% | 233,200 | +109.5% | 0.00% | – |
| Q3 2021 | $1,160,000 | +26.0% | 111,300 | +8.6% | 0.00% | – |
| Q2 2021 | $921,000 | -29.0% | 102,500 | -19.8% | 0.00% | – |
| Q1 2021 | $1,297,000 | – | 127,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |